Home
Conditions
Lymphoma, Large-Cell, Immunoblastic

Clinical trial condition

Lymphoma, Large-Cell, Immunoblastic

Explore clinical trials studying Lymphoma, Large-Cell, Immunoblastic. Study availability and eligibility vary by location and protocol.

372 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Immunoblastic trial results

Completed

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

NCT00795769

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

NCT01427881

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +138 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

NCT00049504

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +160 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

NCT00509691

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

NCT00248547

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

NCT00005988

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +47 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Minnesota Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

NCT00897923

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +50 more
Locations: Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations: Stanford University Palo Alto, California, United States

Norwestern Memorial Hospital Chicago, Illinois, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

NCT00408681

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

NCT01475058

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +27 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Lymphoma, Large-Cell, Immunoblastic

Lymphoma, Large-Cell, Immunoblastic trial results

Related conditions